← Browse by Condition
Medical Condition
squamous cell carcinoma of head and neck
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3, Phase 1
NCT07055841 Phase 2
Recruiting
Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment
69 pts
Location
China
Sponsor
Xiuping Ding
NCT07063212 Phase 2
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Enrollment
500 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
NCT06380816 Phase 1, Phase 2
Recruiting
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Enrollment
167 pts
Location
United Kingdom
Sponsor
Cancer Research UK